These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10958704)

  • 1. Use of SSRIs in the elderly: obvious benefits but unappreciated risks.
    Herrmann N
    Can J Clin Pharmacol; 2000; 7(2):91-5. PubMed ID: 10958704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.
    Peretti S; Judge R; Hindmarch I
    Acta Psychiatr Scand Suppl; 2000; 403():17-25. PubMed ID: 11019931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.
    Draper B; Berman K
    Drugs Aging; 2008; 25(6):501-19. PubMed ID: 18540689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.
    Mace S; Taylor D
    Expert Opin Pharmacother; 2000 Jul; 1(5):917-33. PubMed ID: 11249500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and safety of fluvoxamine and other antidepressants.
    Westenberg HG; Sandner C
    Int J Clin Pract; 2006 Apr; 60(4):482-91. PubMed ID: 16620364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.
    de Abajo FJ
    Drugs Aging; 2011 May; 28(5):345-67. PubMed ID: 21542658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
    Steffens DC; Krishnan KR; Helms MJ
    Depress Anxiety; 1997; 6(1):10-8. PubMed ID: 9394870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly.
    Emslie G; Judge R
    Acta Psychiatr Scand Suppl; 2000; 403():26-34. PubMed ID: 11019932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analytical studies on new antidepressants.
    Anderson IM
    Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics.
    Goldstein BJ; Goodnick PJ
    J Psychopharmacol; 1998; 12(3 Suppl B):S55-87. PubMed ID: 9808079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of serotonergic drugs for treating depression in older patients.
    Haider A; Miller DR; Staton RD
    Geriatrics; 1993 Dec; 48(12):48-51. PubMed ID: 8253394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.